SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-18-157718
Filing Date
2018-05-09
Accepted
2018-05-09 17:22:17
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-1 d583153ds1.htm S-1 173302
2 EX-5.1 d583153dex51.htm EX-5.1 5154
3 EX-23.1 d583153dex231.htm EX-23.1 1886
4 GRAPHIC g583153dsp18.jpg GRAPHIC 4589
5 GRAPHIC g583153dsp4.jpg GRAPHIC 3252
6 GRAPHIC g583153g55f21.jpg GRAPHIC 7272
7 GRAPHIC g583153g90u34.jpg GRAPHIC 6887
  Complete submission text file 0001193125-18-157718.txt   212204
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-224799 | Film No.: 18819517
SIC: 2834 Pharmaceutical Preparations